Skip to main content

Peer Review reports

From: TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation

Original Submission
9 Jun 2023 Submitted Original manuscript
25 Jun 2023 Author responded Author comments - Yosuke Ota
Resubmission - Version 2
25 Jun 2023 Submitted Manuscript version 2
25 Jun 2023 Author responded Author comments - Yosuke Ota
Resubmission - Version 3
25 Jun 2023 Submitted Manuscript version 3
13 Sep 2023 Reviewed Reviewer Report
19 Jan 2024 Reviewed Reviewer Report
29 Jan 2024 Author responded Author comments - Yosuke Ota
Resubmission - Version 4
29 Jan 2024 Submitted Manuscript version 4
30 Jan 2024 Author responded Author comments - Yosuke Ota
Resubmission - Version 5
30 Jan 2024 Submitted Manuscript version 5
11 Mar 2024 Reviewed Reviewer Report
7 May 2024 Reviewed Reviewer Report
17 May 2024 Author responded Author comments - Yosuke Ota
Resubmission - Version 6
17 May 2024 Submitted Manuscript version 6
20 May 2024 Author responded Author comments - Yosuke Ota
Resubmission - Version 7
20 May 2024 Submitted Manuscript version 7
3 Jul 2024 Reviewed Reviewer Report
3 Jul 2024 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
15 Jul 2024 Editorially accepted
25 Jul 2024 Article published 10.1186/s12865-024-00643-x

You can find further information about peer review here.

Back to article page